对于初始心房动,进行切除或药物治疗
Jason G Andrade1,2,3
1University of British Columbia, Vancouver, Canada.
Annals of cardiothoracic surgery
|February 21, 2024
概括
与抗心律失常药物相比,冷气球移除是对心房 (AF) 的优越初始治疗方法. 这种治疗可以减少心律失常的复发,改善生活质量,并可能减缓AF的进展.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 心房动 (AF) 是一种常见的慢性心律障碍.
- 目前的治疗方法,如抗不律性药物 (AADs),有效性和副作用有限.
- 在未接受过治疗的AF中,最佳的初始节律控制策略需要进一步澄清.
研究的目的:
- 评估冷气球除作为心房的初始治疗方法的有效性.
- 为了比较冷却气球移除与传统的抗心律失常药物治疗.
- 评估初始治疗对疾病进展和医疗保健利用的影响.
主要方法:
- 对最近的临床试验进行分析,比较以前未接受过治疗的AF患者的冷热气球移除与抗失常药物.
- 评估结果,包括心房动脉节律失常的复发,症状负担,生活质量和医疗保健资源的利用.
- 评估疾病修饰和进展到高级AF的可能性.
主要成果:
- 结冷气球切除显著减少了心房动脉节律衰退的复发和负担.
- 接受冷气球移除术的患者在症状和生活质量方面经历了显著改善.
- 与AAD相比,冷却气球除导致医疗保健资源利用率下降.
- 导管切除显示出疾病修饰的潜力,减缓了AF的进展.
结论:
- 冰冷气球除是一种有效且可能改变心房的初始治疗方法.
- 这种方法在有效性,生活质量和医疗保健成本方面比抗心律失常药物具有优势.
- 研究结果支持冷气球除作为适合AF患者首选的初始节律控制策略.
相关概念视频
Disturbances in Heart Rhythm
956
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
956
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
744
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
744
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
996
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
996
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


